Church & Dwight Operating Cash Flow decreased by 5.9% to $174.80M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 5.9%, from $185.70M to $174.80M. Over 3 years (FY 2021 to FY 2024), Operating Cash Flow shows an upward trend with a 5.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $244.10M | $309.30M | $340.20M | $152.80M | $157.60M | $223.70M | $351.10M | $273.10M | $236.10M | $285.90M | $235.50M | $263.00M | $236.90M | $364.00M | $292.30M | $185.70M | $174.80M |
| QoQ Change | — | +26.7% | +10.0% | -55.1% | +3.1% | +41.9% | +57.0% | -22.2% | -13.5% | +21.1% | -17.6% | +11.7% | -9.9% | +53.7% | -19.7% | -36.5% | -5.9% |
| YoY Change | — | — | — | — | -35.4% | -27.7% | +3.2% | +78.7% | +49.8% | +27.8% | -32.9% | -3.7% | +0.3% | +27.3% | +24.1% | -29.4% | -5.9% |